Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-30 Purchase |
2021-07-02 5:07 pm |
Larimar Therapeutics Inc. | LRMR | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt III L.P. Deerfield Mgmt HIF L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund III L.P. Deerfield Healthcare Innovations Fund L.P. Deerfield Private Design Fund IV L.P. * Director by Deputization Director 10% Owner |
685,710 | $8.75 | $5,999,963 | 1,943,420 (Indirect) |
View |
| 2021-06-30 Purchase |
2021-07-02 4:08 pm |
Larimar Therapeutics Inc. | LRMR | Hamilton Thomas Edward Director |
56,710 | $8.75 | $496,213 | 349,563 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-10 Option Award |
2022-05-12 8:28 pm |
N/A 2032-05-10 |
Larimar Therapeutics Inc. | LRMR | Truitt Joseph Director |
8,300 | $0 | 8,300 (Direct) |
View |
| 2022-05-10 Option Award |
2022-05-12 8:27 pm |
N/A 2032-05-10 |
Larimar Therapeutics Inc. | LRMR | Barrett Peter Director |
8,300 | $0 | 8,300 (Direct) |
View |
| 2022-05-10 Option Award |
2022-05-12 8:27 pm |
N/A 2032-05-10 |
Larimar Therapeutics Inc. | LRMR | Hamilton Thomas Edward Director |
8,300 | $0 | 8,300 (Direct) |
View |
| 2022-05-10 Option Award |
2022-05-12 8:27 pm |
N/A 2032-05-10 |
Larimar Therapeutics Inc. | LRMR | LEFF JONATHAN S Director |
8,300 | $0 | 8,300 (Direct) |
View |
| 2022-05-10 Option Award |
2022-05-12 8:26 pm |
N/A 2032-05-10 |
Larimar Therapeutics Inc. | LRMR | THOMAS FRANK E Director |
8,300 | $0 | 8,300 (Direct) |
View |
| 2022-05-10 Option Award |
2022-05-11 5:42 pm |
N/A 2032-05-10 |
Larimar Therapeutics Inc. | LRMR | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) * Director by Deputization Director 10% Owner |
8,300 | $0 | 8,300 (Indirect) |
View |
| 2022-01-18 Option Award |
2022-01-20 7:19 pm |
N/A 2032-01-18 |
Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer |
80,000 | $0 | 80,000 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 7:16 pm |
N/A 2032-01-18 |
Larimar Therapeutics Inc. | LRMR | BEN-MAIMON CAROLE President and CEO |
182,000 | $0 | 182,000 (Direct) |
View |
| 2021-05-12 Option Award |
2021-05-20 08:48 am |
N/A 2031-05-12 |
Larimar Therapeutics Inc. | LRMR | Truitt Joseph Director |
8,300 | $0 | 8,300 (Direct) |
View |
| 2021-05-12 Option Award |
2021-05-17 5:17 pm |
N/A 2031-05-12 |
Larimar Therapeutics Inc. | LRMR | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) * Director by Deputization Director 10% Owner |
8,300 | $0 | 8,300 (Indirect) |
View |
| 2021-05-12 Option Award |
2021-05-17 5:09 pm |
N/A 2031-05-12 |
Larimar Therapeutics Inc. | LRMR | LEFF JONATHAN S Director |
8,300 | $0 | 8,300 (Direct) |
View |
| 2021-05-12 Option Award |
2021-05-17 5:08 pm |
N/A 2031-05-12 |
Larimar Therapeutics Inc. | LRMR | Daniel Thomas O Director |
8,300 | $0 | 8,300 (Direct) |
View |
| 2021-05-12 Option Award |
2021-05-17 5:06 pm |
N/A 2031-05-12 |
Larimar Therapeutics Inc. | LRMR | Barrett Peter Director |
8,300 | $0 | 8,300 (Direct) |
View |
| 2021-05-12 Option Award |
2021-05-17 5:04 pm |
N/A 2031-05-12 |
Larimar Therapeutics Inc. | LRMR | THOMAS FRANK E Director |
8,300 | $0 | 8,300 (Direct) |
View |
| 2021-05-12 Option Award |
2021-05-17 4:59 pm |
N/A 2031-05-12 |
Larimar Therapeutics Inc. | LRMR | Hamilton Thomas Edward Director |
8,300 | $0 | 8,300 (Direct) |
View |
| 2021-01-19 Option Award |
2021-01-21 10:56 am |
N/A 2031-01-19 |
Larimar Therapeutics Inc. | LRMR | BEN-MAIMON CAROLE President and CEO |
106,700 | $0 | 106,700 (Direct) |
View |
| 2021-01-19 Option Award |
2021-01-21 10:55 am |
N/A 2031-01-19 |
Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer |
42,000 | $0 | 42,000 (Direct) |
View |
| 2020-09-29 Option Award |
2020-10-01 4:27 pm |
N/A 2030-07-16 |
Larimar Therapeutics Inc. | LRMR | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) * Director by Deputization Director 10% Owner |
16,600 | $0 | 16,600 (Indirect) |
View |
| 2020-09-29 Option Award |
2020-09-30 2:14 pm |
N/A 2030-07-16 |
Larimar Therapeutics Inc. | LRMR | Hamilton Thomas Edward Director |
16,600 | $0 | 16,600 (Direct) |
View |
| 2020-09-29 Option Award |
2020-09-30 2:12 pm |
N/A 2030-07-16 |
Larimar Therapeutics Inc. | LRMR | Daniel Thomas O Director |
16,600 | $0 | 16,600 (Direct) |
View |
| 2020-09-29 Option Award |
2020-09-30 2:09 pm |
N/A 2030-07-16 |
Larimar Therapeutics Inc. | LRMR | Barrett Peter Director |
16,600 | $0 | 16,600 (Direct) |
View |
| 2020-09-29 Option Award |
2020-09-30 2:05 pm |
N/A 2030-07-16 |
Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer |
84,100 | $0 | 84,100 (Direct) |
View |
| 2020-09-29 Option Award |
2020-09-30 2:00 pm |
N/A 2030-07-16 |
Larimar Therapeutics Inc. | LRMR | Truitt Joseph Director |
16,600 | $0 | 16,600 (Direct) |
View |
| 2020-09-29 Option Award |
2020-09-30 1:58 pm |
N/A 2030-07-16 |
Larimar Therapeutics Inc. | LRMR | LEFF JONATHAN S Director |
16,600 | $0 | 16,600 (Direct) |
View |
| 2020-09-29 Option Award |
2020-09-30 1:52 pm |
N/A 2030-07-16 |
Larimar Therapeutics Inc. | LRMR | THOMAS FRANK E Director |
16,600 | $0 | 16,600 (Direct) |
View |
| 2020-09-29 Option Award |
2020-09-30 1:50 pm |
N/A 2030-07-16 |
Larimar Therapeutics Inc. | LRMR | BEN-MAIMON CAROLE President and CEO |
411,400 | $0 | 411,400 (Direct) |
View |
| 2020-06-26 Other |
2020-06-30 5:02 pm |
N/A N/A |
Larimar Therapeutics Inc. | LRMR | Hamilton Thomas Edward Director |
292,853 | $0 | 719,126 (Direct) |
View |
| 2020-06-26 Other |
2020-06-30 5:01 pm |
N/A N/A |
Larimar Therapeutics Inc. | LRMR | CHONDRIAL THERAPEUTICS HOLDINGS LLC 10% Owner |
6,091,242 | $0 | 6,091,250 (Direct) |
View |
| 2020-06-26 Other |
2020-06-30 5:00 pm |
N/A N/A |
Larimar Therapeutics Inc. | LRMR | BEN-MAIMON CAROLE President and CEO |
25,083 | $0 | 50,166 (Direct) |
View |
Ownership |
2020-06-08 6:03 pm |
N/A N/A |
Larimar Therapeutics Inc. | LRMR | Flynn James E Deerfield Mgmt III L.P. Deerfield Mgmt IV L.P. Deerfield Mgmt HIF L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund III L.P. Deerfield Private Design Fund IV L.P. Deerfield Healthcare Innovations Fund L.P. Director by Deputization Director 10% Owner |
0 | $0 | 6,091,250 (Indirect) |
View |
Ownership |
2020-06-05 8:13 pm |
N/A N/A |
Larimar Therapeutics Inc. | LRMR | CHONDRIAL THERAPEUTICS HOLDINGS LLC 10% Owner |
0 | $0 | 6,091,250 (Direct) |
View |
| 2020-05-28 Option Award |
2020-06-05 8:04 pm |
N/A 2030-05-28 |
Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer |
60,479 | $0 | 60,479 (Direct) |
View |
Ownership |
2020-06-05 7:52 pm |
N/A 2029-05-28 |
Larimar Therapeutics Inc. | LRMR | BEN-MAIMON CAROLE President and CEO |
0 | $0 | 194,559 (Direct) |
View |